{"schema_version":"secwatch.filing_event.v1","accession":"0001832511-26-000010","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.440134+00:00","generated_at":"2026-05-15T08:53:06.370776+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"P3 Health Partners reports Q4 net loss $165.7M, provides 2026 EBITDA guidance midpoint $10M","bullets":["Q4 2025 revenue $384.8M, net loss $165.7M, adjusted EBITDA loss $76.1M.","Full-year 2025 revenue $1.46B, net loss $323.1M, adjusted EBITDA loss $161.3M.","At-risk membership declined ~9% to ~115,000 in Q4 due to network realignment.","2026 guidance: adjusted EBITDA range -$20M to +$40M, midpoint $10M, ~$170M YoY improvement.","Normalized full-year adjusted EBITDA loss improved to $149.1M from $193.0M in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001832511-26-000010","json":"https://secwatch.observer/filing/0001832511-26-000010.json","markdown":"https://secwatch.observer/filing/0001832511-26-000010.md","text":"https://secwatch.observer/filing/0001832511-26-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000010/0001832511-26-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000010/piii-20260326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:53:06.370776+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"908e0d1c35c1dc730951f951d585586693d1998a","claim":"P3 Health Partners Inc. reported financial results for the year ended December 31, 2025.","evidence_excerpt":"On March 26, 2026, P3 Health Partners Inc. (the “Company”) announced its financial results for the year ended December 31, 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000010/0001832511-26-000010-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2025"},{"label":"Result","value":"reported results"}]},{"claim_id":"a393b13b0ff5f990838ceac69f84470c7624b694","claim":"P3 Health Partners Inc. reported financial results for the fourth quarter ended December 31, 2025.","evidence_excerpt":"P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000010/0001832511-26-000010-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2025"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}